TY - JOUR
T1 - Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE)
T2 - an international observational study
AU - Langhorne, Peter
AU - O'Donnell, Martin J.
AU - Chin, Siu Lim
AU - Zhang, Hongye
AU - Xavier, Denis
AU - Avezum, Alvaro
AU - Mathur, Nandini
AU - Turner, Melanie
AU - Macleod, Mary Joan
AU - Lopez-Jaramillo, Patricio
AU - Damasceno, Albertino
AU - Hankey, Graeme J.
AU - Dans, Antonio L.
AU - Elsayed, Ahmed
AU - Mondo, Charles
AU - Wasay, Mohammad
AU - Czlonkowska, Anna
AU - Weimar, Christian
AU - Yusufali, Afzal Hussein
AU - Hussain, Fawaz Al
AU - Lisheng, Liu
AU - Diener, Hans-Christoph
AU - Ryglewicz, Danuta
AU - Pogosova, Nana
AU - Iqbal, Romana
AU - Diaz, Rafael
AU - Yusoff, Khalid
AU - Oguz, Aytekin
AU - Wang, Xingyu
AU - Penaherrera, Ernesto
AU - Lanas, Fernando
AU - Ogah, Okechukwu S.
AU - Ogunniyi, Adesola
AU - Iversen, Helle K.
AU - Malaga, German
AU - Rumboldt, Zvonko
AU - Magazi, Daliwonga
AU - Nilanont, Yongchai
AU - Rosengren, Annika
AU - Oveisgharan, Shahram
AU - INTERSTROKE collaborators
AU - Yusuf, Salim
N1 - The current analysis was supported by a grant from Chest, Heart and Stroke Scotland. The main INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland (Sweden), and through unrestricted grants from several pharmaceutical companies with major contributions from AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD, Swedish Heart and Lung Foundation, Chest, Heart and Stroke Scotland, and The Stroke Association, with support from The UK Stroke Research Network. The Department of Neurology at the University Duisburg-Essen received research grants awarded to H-CD from the German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, National Institutes of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation.
PY - 2018/5/19
Y1 - 2018/5/19
N2 - Background Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels.Methods We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13 447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month.Findings We obtained full information for 12 342 (92%) of 13 447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0·0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1·29; 95% CI 1·14–1·44; all p<0·0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1·39; 1·12–1·72) irrespective of other patient and service characteristics.Interpretation Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes.
AB - Background Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels.Methods We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13 447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month.Findings We obtained full information for 12 342 (92%) of 13 447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0·0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1·29; 95% CI 1·14–1·44; all p<0·0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1·39; 1·12–1·72) irrespective of other patient and service characteristics.Interpretation Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes.
KW - stroke unit
KW - stroke management
KW - outcome
KW - antiplatelet therapy
KW - care processes
U2 - 10.1016/S0140-6736(18)30802-X
DO - 10.1016/S0140-6736(18)30802-X
M3 - Article
VL - 391
SP - 2019
EP - 2027
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 10134
ER -